{"DataElement":{"publicId":"2180659","version":"1","preferredName":"Death Protocol Treatment Related Specify","preferredDefinition":"the text field to describe a problem or symptom related to protocol treatment which may have contributed to the patient's death.","longName":"DEA_PROT_TX_R/T_SPEC","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195856","version":"1","preferredName":"Death Protocol Treatment","preferredDefinition":"information related to the protocol treatment-related death.","longName":"DEATH_PROT_TX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2442623","version":"1","preferredName":"Death","preferredDefinition":"The absence of life or state of being dead.","longName":"C28554","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09046428-51D0-6C1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-05","endDate":null,"createdBy":"HEGDES","dateCreated":"2006-01-05","modifiedBy":"ONEDATA","dateModified":"2006-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2640537","version":"1","preferredName":"Protocol Therapy","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C25320:C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"310EB23E-3365-2BB5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-22","modifiedBy":"ONEDATA","dateModified":"2007-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDF636A9-9989-54D0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018370","version":"1","preferredName":"Adverse Event Specify","preferredDefinition":"the free text field to specify an adverse event.","longName":"AE_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30723CB-0BFA-05D8-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-10-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"CAMPBELB","dateModified":"2008-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811955","version":"1","longName":"Follow-up","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"},{"publicId":"2811944","version":"1","longName":"NonHodgkins Lymphoma","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4171052","version":"1","longName":"RTOG-0920","context":"NRG"}]}],"AlternateNames":[{"name":"DEA_PROT_TX_R/T_SPEC","type":"USED_BY","context":"NRG"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"OTHSP_SECDTH_DDORRES","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Other specify","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Due to protocol treatment, specify","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Specify","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D20F5991-72FD-3910-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-29","modifiedBy":"ALAIS","dateModified":"2020-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}